The Brilacidin news is such a disruptive technology that most probably expect it to come out in a journal paper or major scientific convention. Not a company pr. This may be part of why the market hasn't reacted yet. They are waiting for definitive proof of what CTIX has. What we have in Brilacidin alone is quite amazing.
Potential investors need to read these last three press releases again.